Recent work from various scientific groups unraveled that the NF-κB pathway is frequently activated in ABC DLBCL by either gain- or loss-of-function mutations affecting upstream members of the NF-κB signaling cascade [26,27,28,29,30]. Here, NFKB1 is linked to diffuse large B-cell lymphoma.